APT(SH:688617) Sou Hu Cai Jing·2025-10-24 22:43Core Viewpoint - 惠泰医疗 reported its Q3 2025 financial results, showing stable revenue and profit figures despite slight declines in some key financial ratios [1] Financial Performance - Total revenue for the company reached 1.867 billion yuan [1] - Net profit attributable to shareholders was 623 million yuan [1] - Net cash inflow from operating activities amounted to 676 million yuan [1] Financial Ratios - The latest debt-to-asset ratio is 12.24%, an increase of 0.03 percentage points from the previous quarter [1] - Gross profit margin stands at 73.19%, a decrease of 0.32 percentage points compared to the last quarter [1] - Return on equity (ROE) is 20.85%, down 1.26 percentage points from the same period last year [1] Earnings and Turnover - Diluted earnings per share are 4.42 yuan [1] - Total asset turnover ratio is 0.58 times [1] - Inventory turnover ratio is 1.15 times [1] Shareholder Information - The number of shareholders is 5,690 [1] - The top ten shareholders hold a total of 82.099 million shares, accounting for 58.22% of the total share capital [1]